Related Experiment Videos
[Plasma fibronectin. Role in severe infections and intensive care]
Presse Medicale (Paris, France : 1983)
|April 23, 1983
Abstract:
Plasma fibronectin (pFN) levels were measured in 52 patients throughout their stay in an intensive care unit. At the same time a close watch was kept for signs of sepsis. Low pFN levels regularly accompanied--but did not precede--infectious episodes and were also found in patients without septic complications. These findings indicate that a fall in pFN does not constitute a factor of increased susceptibility to infection.
Insights
Low plasma fibronectin (pFN) levels in ICU patients did not predict infection. These levels were often low during infections but also occurred in non-septic patients, suggesting they don't increase infection susceptibility.
Area of Science:
- Critical care medicine
- Biochemistry
- Infectious disease diagnostics
Background:
- Plasma fibronectin (pFN) is a glycoprotein involved in immune response.
- Assessing biomarkers for infection risk in intensive care units (ICUs) is crucial.
Observation:
- pFN levels were monitored in 52 ICU patients.
- Patients were closely observed for clinical signs of sepsis.
- Concurrent measurements of pFN and sepsis indicators were performed.
Findings:
- A decline in pFN levels was observed to accompany infectious episodes.
- Decreased pFN levels did not consistently precede the onset of infections.
- Low pFN levels were also detected in patients who did not develop septic complications.
Implications:
- The study suggests that a drop in pFN is not a reliable indicator of increased susceptibility to infection.
- pFN levels alone may not be sufficient for predicting sepsis development in ICU settings.
- Further research may explore the role of pFN in the context of critical illness and infection.